Kubitza, Dagmar
Willmann, Stefan
Becka, Michael
Thelen, Kirstin
Young, Guy
Brandão, Leonardo R.
Monagle, Paul
Male, Christoph
Chan, Anthony
Kennet, Gili
Martinelli, Ida
Saracco, Paola
Lensing, Anthonie W. A.
Funding for this research was provided by:
Bayer
Janssen Research and Development
Article History
Received: 6 September 2018
Accepted: 29 October 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: The protocol was approved by the Institutional Review Board or Ethics Committee of each participating center, if required, and de-identified data was retrieved.
: Not applicable.
: DK, SW, MB, KT and AWAL are employees of Bayer. GY, AC, PS, and PM have no competing to report. LRB has received research funds from Sanofi Aventis, and has received honoraria from Bayer and from Boehringer Ingelheim. CM has received honoraria from Bayer AG, Boehringer Ingelheim, and Bristol-Myers Squibb. GK has received honoraria from OPKO biologics, Bayer, Pfizer, CSL, Alnylam, Shire and Roche. IM has received consultancy fees from Bayer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.